Last reviewed · How we verify
NCT06130631
Predictors of Steroid Response in Childhood Nephrotic Syndrome
trial in Nephrotic Syndrome in Children in 79 participants. Status unknown.
21 December 2024
Quick facts
| Lead sponsor | Maha Radwan |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 79 |
| Start date | 3 December 2023 |
| Primary completion | 21 December 2024 |
| Estimated completion | 31 May 2025 |
Conditions studied
- Nephrotic Syndrome in Children — all drugs for Nephrotic Syndrome in Children →
Sponsor
Maha Radwan
Who can join
Adults 12 Months to 18, any sex, with Nephrotic Syndrome in Children. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Retrospective study of predictors of steroid response in childhood nephrotic syndrom
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06130631
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Nephrotic Syndrome in Children
Currently open trials in the same condition.
- NCT07091175 — Dupilumab Therapy in Nephrotic Syndrome in Children · Phase 2 · recruiting
- NCT07087314 — A Study of Anti-CD38 Monoclonal Antibody (SG301) Subcutaneous Injection in Children With Nephrotic Syndrome With Frequen · Phase 2 · recruiting
- NCT06635720 — REduced-dose Steroid PrOtocol for Childhood Nephrotic SyndromE (RESPONSE) · Phase 3 · recruiting
- NCT06125405 — Study of the Telitacicept in Pediatric Patients With Frequently Relapsing or Steroid Dependent Nephrotic Syndrome · Phase 3 · recruiting
- NCT06079788 — Study of Adrenocorticotropic Hormone on Children With Frequent Relapse or Steroid-dependent Nephrotic Syndrome: a Prospe · Phase 3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06130631 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Maha Radwan
- Last refreshed: 14 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06130631.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing